Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2021-06-01 (4 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: RUEIL-MALMAISON (92500), Hauts-de-Seine
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELARL PHARMACIE GALOULA : revenue, balance sheet and financial ratios
SELARL PHARMACIE GALOULA is a French company
founded 4 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in RUEIL-MALMAISON (92500),
this company of category PME
shows in 2025 a net income negative of -46 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE GALOULA (SIREN 899641609)
Indicator
2025
2024
2023
2022
Revenue
N/C
N/C
N/C
N/C
Net income
-46 446 €
-23 071 €
78 886 €
319 714 €
EBITDA
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, SELARL PHARMACIE GALOULA records a net loss of 46 k€. This deficit will reduce equity on the balance sheet.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
-46 446 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 83%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 30%. The balance between equity and debt is satisfactory.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
83.463%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
29.681%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2022
2023
2024
2025
Debt ratio
28.251
80.333
50.396
83.463
Financial autonomy
50.749
39.25
42.001
29.681
Repayment capacity
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
Sector positioning
Debt ratio
83.462025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Average+7 pts over 3 years
In 2025, the debt ratio of SELARL PHARMACIE GALOULA (83.46) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
29.68%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Average-13 pts over 3 years
In 2025, the financial autonomy of SELARL PHARMACIE GALOULA (29.7%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 121.73. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2022
2023
2024
2025
Liquidity ratio
229.246
235.063
174.275
121.731
Interest coverage
None
None
None
None
Sector positioning
Liquidity ratio
121.732025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Watch-41 pts over 3 years
In 2025, the liquidity ratio of SELARL PHARMACIE GALOULA (121.73) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Positioning of SELARL PHARMACIE GALOULA in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE GALOULA with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE GALOULA
What is the revenue of SELARL PHARMACIE GALOULA ?
The revenue of SELARL PHARMACIE GALOULA is not publicly disclosed (confidential accounts filed with INPI).
Is SELARL PHARMACIE GALOULA profitable?
SELARL PHARMACIE GALOULA recorded a net loss in 2025.
Where is the headquarters of SELARL PHARMACIE GALOULA ?
The headquarters of SELARL PHARMACIE GALOULA is located in RUEIL-MALMAISON (92500), in the department Hauts-de-Seine.
Where to find the tax return of SELARL PHARMACIE GALOULA ?
The tax return of SELARL PHARMACIE GALOULA is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE GALOULA operate?
SELARL PHARMACIE GALOULA operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart